ArticleFrontiers in pharmacology2026
Hypoglycemia aggravates cognitive degeneration by activating endothelial ZBP1-mediated PANoptosis in type 2 diabetic mice.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Recurrent hypoglycemia increases cognitive impairment in diabetic patients. Following cerebral neuron injury, endothelial cells provide morphological, metabolic, and immune support to damaged neurons, but the inflammatory mechanism underlying hippocampal neuron degeneration remains unclear. Methods: The Morris water maze test was performed to measure cognitive changes in type 2 diabetic mice. ZBP1 expression was knocked down via small interfering RNA transfection in bEnd.3 brain endothelial cells. Results: PANoptosis, a defined form of programmed cell death (PCD), was increased by hypoglycemia in the hippocampus of diabetic mice in vivo and by low glucose in bEnd.3 cells in vitro. ZBP1 knockdown reduced low-glucose-induced PANoptosis in high-glucose-cultivated bEnd.3 cells. RNA transcriptomics sequencing revealed that AGE-RAGE signaling was significantly altered after ZBP1 knockdown, which was confirmed by biochemical data. Discussion: Hypoglycemia impairs cognition in diabetic mice by activating brain endothelial ZBP1-mediated PANoptosis via the AGE-RAGE axis. Targeting ZBP1 may represent a novel therapeutic strategy for diabetes-associated cognitive dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.